Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PILOT: Long-term immune response to Prevnar 13 in previously vaccinated versus Prevnar-naive cohorts
2014-004158-32Phase 2
- Sponsor
- Pfizer
- Start
- Apr 2015
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of Prevnar 13 in pneumococcal disease (2 arms), sponsored by Pfizer.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2014-004158-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004158-32.